Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEARCA:ALAINYSEARCA:AUGMNYSEMKT:IGCNYSEARCA:MMIT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeALAIAlger AI Enablers & Adopters ETF$30.17-2.2%$27.26$18.73▼$31.07$69.83M1.9914,652 shs20,886 shsAUGMFt Vest Us Eq Max Buf Aug$32.84-0.1%$32.26$30.83▼$32.88$20.69MN/A3,120 shs1,416 shsIGCIGC Pharma$0.31-6.5%$0.31$0.25▼$0.50$24.50M1.48338,621 shs214,616 shsMMITNYLI MacKay Shields Municipal Intermediate ETF$23.82+0.1%$23.75$22.99▼$24.65$1.02B0.11202,251 shs89,704 shs20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceALAIAlger AI Enablers & Adopters ETF+0.75%+5.47%+11.82%+32.57%+39.69%AUGMFt Vest Us Eq Max Buf Aug+0.03%+0.67%+1.48%+3.59%+3,286,999,900.00%IGCIGC Pharma0.00%+0.65%-2.84%+8.07%+30,799,900.00%MMITNYLI MacKay Shields Municipal Intermediate ETF+0.17%+0.21%+0.38%-0.58%-1.36%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationALAIAlger AI Enablers & Adopters ETFN/AN/AN/AN/AN/AN/AN/AN/AAUGMFt Vest Us Eq Max Buf AugN/AN/AN/AN/AN/AN/AN/AN/AIGCIGC Pharma1.9145 of 5 stars3.50.00.00.02.21.70.0MMITNYLI MacKay Shields Municipal Intermediate ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceALAIAlger AI Enablers & Adopters ETF 2.87Moderate Buy$30.17N/AAUGMFt Vest Us Eq Max Buf Aug 0.00N/AN/AN/AIGCIGC Pharma 3.00Buy$3.881,170.49% UpsideMMITNYLI MacKay Shields Municipal Intermediate ETF 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookALAIAlger AI Enablers & Adopters ETFN/AN/AN/AN/AN/AN/AAUGMFt Vest Us Eq Max Buf AugN/AN/AN/AN/AN/AN/AIGCIGC Pharma$1.24M19.66N/AN/A$0.08 per share3.81MMITNYLI MacKay Shields Municipal Intermediate ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateALAIAlger AI Enablers & Adopters ETFN/AN/A32.23∞N/AN/AN/AN/AN/AAUGMFt Vest Us Eq Max Buf AugN/AN/A0.00∞N/AN/AN/AN/AN/AIGCIGC Pharma-$13M-$0.11N/AN/AN/A-714.16%-122.44%-88.40%N/AMMITNYLI MacKay Shields Municipal Intermediate ETFN/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthALAIAlger AI Enablers & Adopters ETF$0.170.56%N/AN/AN/AAUGMFt Vest Us Eq Max Buf AugN/AN/AN/AN/AN/AIGCIGC PharmaN/AN/AN/AN/AN/AMMITNYLI MacKay Shields Municipal Intermediate ETF$0.873.65%N/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioALAIAlger AI Enablers & Adopters ETFN/AN/AN/AAUGMFt Vest Us Eq Max Buf AugN/AN/AN/AIGCIGC Pharma0.021.150.98MMITNYLI MacKay Shields Municipal Intermediate ETFN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipALAIAlger AI Enablers & Adopters ETFN/AAUGMFt Vest Us Eq Max Buf AugN/AIGCIGC Pharma3.87%MMITNYLI MacKay Shields Municipal Intermediate ETFN/AInsider OwnershipCompanyInsider OwnershipALAIAlger AI Enablers & Adopters ETFN/AAUGMFt Vest Us Eq Max Buf AugN/AIGCIGC Pharma31.48%MMITNYLI MacKay Shields Municipal Intermediate ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableALAIAlger AI Enablers & Adopters ETFN/A2.31 millionN/AN/AAUGMFt Vest Us Eq Max Buf AugN/A630,000N/AN/AIGCIGC Pharma6179.69 million54.60 millionN/AMMITNYLI MacKay Shields Municipal Intermediate ETFN/A42.80 millionN/ANot OptionableALAI, MMIT, IGC, and AUGM HeadlinesRecent News About These CompaniesIndexIQ Launches 6th MacKay Shields ETFMay 31, 2024 | etftrends.comENew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesWhy BigBear.ai Could Rally 100% and Catch Palantir SoonBy Gabriel Osorio-Mazilli | June 30, 2025View Why BigBear.ai Could Rally 100% and Catch Palantir SoonIPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBy Dan Schmidt | June 20, 2025View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBigBear.ai Poised to Benefit as Palantir Dominates AI DefenseBy Gabriel Osorio-Mazilli | June 23, 2025View BigBear.ai Poised to Benefit as Palantir Dominates AI DefenseIntel's Price Spikes: Noise, or the First Notes of a Turnaround?By Jeffrey Neal Johnson | June 13, 2025View Intel's Price Spikes: Noise, or the First Notes of a Turnaround?AT&T: Is This Telecom Giant a Buy or a Bye for Your Portfolio?By Jeffrey Neal Johnson | June 5, 2025View AT&T: Is This Telecom Giant a Buy or a Bye for Your Portfolio?ALAI, MMIT, IGC, and AUGM Company DescriptionsAlger AI Enablers & Adopters ETF NYSEARCA:ALAI$30.17 -0.68 (-2.20%) As of 02:24 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.The Alger AI Enablers & Adopters ETF (ALAI) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is actively managed, investing in firms benefiting from developing, integrating or enabling artificial intelligence (AI) technology. The fund seeks long-term capital growth through fundamental research ALAI was launched on Apr 4, 2024 and is issued by Alger.Ft Vest Us Eq Max Buf Aug NYSEARCA:AUGM$32.84 -0.03 (-0.09%) As of 09:30 AM EasternThe FT Vest U.S. Equity Max Buffer ETF - August (AUGM) is an exchange-traded fund that mostly invests in large cap equity. The fund seeks to provide a pre-determined investment outcome over a one year period. The exposure is reset annually in August AUGM was launched on Aug 16, 2024 and is issued by First Trust.IGC Pharma NYSEMKT:IGC$0.30 -0.02 (-6.47%) As of 02:23 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.IGC Pharma, Inc., a clinical stage pharmaceutical company, engages in developing treatments for Alzheimer's disease. The company's lead product is IGC-AD1, which is in a Phase 2B clinical trial as a treatment for agitation in dementia due to Alzheimer's; and TGR-63, IGC-1C, IGC-M3, and LMP in pre-clinical development. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. The company was incorporated in 2005 and is headquartered in Potomac, Maryland.NYLI MacKay Shields Municipal Intermediate ETF NYSEARCA:MMIT$23.82 +0.03 (+0.11%) As of 02:24 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.The IQ MacKay Municipal Intermediate ETF (MMIT) is an exchange-traded fund that mostly invests in investment grade fixed income. The fund is actively managed to provide enhanced total-return potential by investing mainly in investment-grade, AMT-free US municipal bonds with duration between 3-10 years. MMIT was launched on Oct 18, 2017 and is managed by IndexIQ. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 2 Reasons to Buy Trade Desk Stock Now and 1 Warning Sign 2 Under the Radar Space & Defense Stocks With Huge Potential Palantir’s $100M Nuclear OS Pact Boosts Bullish Case Joby Stock Soars as Piloted Flights in Dubai Signal a New Era Tesla’s Robotaxi Hype Fuels Bullish Price Targets to $500 S&P 500 All-Time Highs: 5 Catalysts Driving It Higher The Top Insider Sells From Q2: Buy, Sell, or Hold? 5 High-Yielding ETFs to Buy and Hold Forever Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
